Ceccarelli Ceccarelli Daniela, Paleari Renata, Solerte Bruno, Mosca Andrea
Dip. di Medicina Interna e Terapia Medica, Università degli Studi di Pavia, Pavia, Italy.
Dip. di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milano, Italy.
Clin Chim Acta. 2022 Jan 1;524:146-153. doi: 10.1016/j.cca.2021.11.009. Epub 2021 Nov 9.
The decline of the estimated glomerular filtration rate (eGFR) and the presence of albuminuria are the typical hallmarks of kidney disease arising as one of the most frequent diabetic complications over a long period of time, generally known as diabetic nephropathy or diabetes kidney disease (DKD). However, a decline in the renal function may occur in diabetic patients for other reasons unrelated to glycemic control, and this condition is known as non-diabetic kidney disease (NDKD). In this opinion paper we will review these conditions, and we outline the importance of other investigations, such as kidney biopsy and the measurement of novel biomarkers, in order to identify the disease progression early, and to allow a timely intervention. We will also focus on the actual limits of the quantitative measurements of albumin in urine, especially with regards to potential interferences due to the treatment of patients with statins.
估算肾小球滤过率(eGFR)下降和蛋白尿的出现是肾脏疾病的典型特征,肾脏疾病是长期以来最常见的糖尿病并发症之一,通常称为糖尿病肾病或糖尿病性肾脏疾病(DKD)。然而,糖尿病患者的肾功能下降可能由与血糖控制无关的其他原因引起,这种情况称为非糖尿病性肾脏疾病(NDKD)。在这篇观点论文中,我们将对这些情况进行综述,并概述其他检查的重要性,如肾活检和新型生物标志物的测量,以便早期识别疾病进展,并及时进行干预。我们还将关注尿白蛋白定量测量的实际局限性,尤其是他汀类药物治疗患者可能产生的干扰。